Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Condition:   Zika Virus Interventions:   Biological: mRNA-1893;   Other: Placebo Sponsors:   ModernaTX, Inc.;   Biomedical Advanced Research and Development Authority Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials